Medicare Price Cuts on 10 Drugs, Biggest 79% Drop This Year
Medicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
Learn how to choose between price and TRI indices for benchmarking your investments. This quick intro explains key differences and why the right choice matters for performance comparison.
27,883 articlesMedicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
Capri Holdings stands at a pivotal moment as capri (cpri) 2026 earnings hinge on brand mix, DTC momentum, and cost co...
As ATS gears up for its Q4 2026 results, investors want clarity on revenue momentum, margins, and guidance. This arti...
Jim Cramer remains wary of Salesforce as growth slows and CIOs shift budgets to less expensive software. He argues th...
Warren Buffett’s latest move at Berkshire Hathaway signals a rare, hands-on embrace of a mega-stock. This piece break...
Regulators revived a stalled pipeline, prompting questions for investors in Sable Offshore. This guide breaks down wh...
Fairholme trimmed its stake in The St. Joe Company, but that doesn’t mean the stock isn’t worth a closer look. Here’s...
AbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
Pixelworks' 2025 earnings cycle highlights a niche semiconductor with rising AI-driven display capabilities. This art...
Rockwell Medical is a niche player in renal care. This analysis breaks down rockwell medical (rmti) earnings, what th...
Eli Lilly shares surged to fresh highs, underpinned by upbeat analyst notes and strong pipeline momentum. This guide ...
Headwinds have pressured Vornado, but two strategic catalysts could unlock meaningful upside. This guide breaks down ...